201. アンジェルマン症候群 [臨床試験数:19,薬物数:30(DrugBank:7),標的遺伝子数:22,標的パスウェイ数:20

Searched query = "Angelman syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02056665January 20145/2/2014Study to Evaluate the Efficacy and Safety of Minocycline in Angelman SyndromeRandomized Clinical Trial, Placebo Compared to Evaluate the Efficacy and Safety of Minocycline in Angelman SyndromeAngelman SyndromeDrug: MINOCYCLINE;Drug: PLACEBO (for Minocycline)Puerta de Hierro University HospitalNULLCompleted6 Years30 YearsBoth32Phase 2Spain
2EUCTR2013-002154-67-ES26/12/201316/09/2013STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME (A-MANECE STUDY)RANDOMIZED CLINICAL TRIAL, PLACEBO COMPARED TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME (A-MANECE STUDY) - A-MANECE Angelman Syndrome
MedDRA version: 16.0Level: PTClassification code 10049004Term: Angelman's syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Aknemin 50
INN or Proposed INN: MINOCYCLINE
Other descriptive name: MINOCYCLINE HYDROCHLORIDE
Dra. Cristina Avendaño SoláNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Spain
3NCT01531582April 20125/2/2012Minocycline in the Treatment of Angelman SyndromeThe Efficacy of Minocycline in the Treatment of Angelman SyndromeAngelman SyndromeDrug: minocyclineUniversity of South FloridaNULLActive, not recruiting4 Years12 YearsBoth25N/AUnited States